Inventor · disambiguated record
Manish Kumar Gupta
Also filed as: GUPTA MANISH · GUPTA MANISH KUMAR
1 granted patent·17 pending applications·1 citations·filing 2005–2024
16Inventor score
Top patents by PatentIndex Score
18 records- 0178US12435154B2Bispecific antibodies against CD3 and CD20GENMAB AS·Filed 2021·Granted Oct 7, 2025·1 cites·29 claims
- 0273US2022211713A1Compositions Containing IbrutinibJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0370US2020171036A1Compositions Containing IbrutinibJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 0464US2023364090A1Formulations/compositions comprising a btk inhibitorJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0562US2025099464A1Pharmaceutical compositionsVIIV HEALTHCARE UK NO 3 LTD·Filed 2024·Application pending·0 cites
- 0656US2022331307A1Dispersible compositionsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0756US2024109972A1Antibody and taxane combination therapyGENMAB AS·Filed 2021·Application pending·0 cites
- 0855US2017252344A1Compositions Containing IbrutinibJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 0955US2021169888A1Formulations/compositions comprising a btk inhibitorJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1054US2022339157A1Formulations/Compositions Comprising a BTK InhibitorJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1152US2016287594A1Compositions Containing IbrutinibJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 1251US2023087164A1Antibodies for use in therapyGENMAB AS·Filed 2021·Application pending·0 cites
- 1348US2022315661A1Dosage regimens for a combination of anti-dr5 antibodies for use in treating cancerGENMAB BV·Filed 2020·Application pending·0 cites
- 1446US2005250132A1Real-time polymerase chain reaction-based genotyping assay for chemokine receptor (CXCR2) single nucleotide polymorphismMELBOHM BERND·Filed 2005·Application pending·0 cites
- 1540US2019290650A1Formulations/compositions comprising a btk inhibitorJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 1635US2019282577A1Formulations/compositions comprising a btk inhibitorJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 1735US2005153353A1Real-time polymerase chain reaction-based genotyping assay for beta2-adrenergic receptor single nucleotide polymorphismFiled 2005·Application pending·0 cites
- 1832US2018000810A1Dispersible compositionsJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Manish Kumar Gupta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →